Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma

被引：27
作者：
Lee, Min Jung [1 ]
Wickner, Paige [1 ]
Fanning, Laura [1 ]
Schlossman, Robert [2 ]
Richardson, Paul [3 ]
Laubach, Jacob [2 ]
Castells, Maria [1 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 167卷 / 01期
关键词：
allergy; multiple myeloma; myeloma therapy; desensitization; lenalidomide;
D O I：
10.1111/bjh.12925
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：127 / 131
页数：5
相关论文
共 50 条
[31]   Lenalidomide in multiple myeloma [J].
Kim, Young ;
Schmidt-Wolf, Ingo G. H. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) :491-497
[32]   Lenalidomide in Myelodysplastic Syndrome and Multiple Myeloma [J].
Sachin R. Shah ;
Thu M. Tran .
Drugs, 2007, 67 :1869-1881
[33]   Continued treatment with lenalidomide in multiple myeloma [J].
Sánchez J.M. .
Advances in Therapy, 2011, 28 (Suppl 8) :1-13
[34]   Lenalidomide use in multiple myeloma (Review) [J].
Zhang, Chao-Wei ;
Wang, Ya-Nan ;
Ge, Xue-Ling .
MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (01)
[35]   Thalidomide and lenalidomide in the treatment of multiple myeloma [J].
Kumar, Shaji ;
Rajkumar, S. Vincent .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (11) :1612-1622
[36]   Lenalidomide: A new therapy for multiple myeloma [J].
Palumbo, Antonio ;
Miguel, Jesus San ;
Sonneveld, Pieter ;
Moreau, Philippe ;
Drach, Johannes ;
Morgan, Gareth ;
Einsele, Hermann .
CANCER TREATMENT REVIEWS, 2008, 34 (03) :283-291
[37]   Rapid subcutaneous desensitization for the management of delayed hypersensitivity reactions to omalizumab:A case report [J].
Gan, Hui ;
Wang, Ling ;
Fu, Wei ;
Zhang, Jinjin ;
Yu, Mingxia ;
Liu, Guanghui .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (03) :486-488
[38]   Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies [J].
Vega, Arantza ;
Pena, M. Isabel ;
Torrado, Ines .
FRONTIERS IN ALLERGY, 2022, 2
[39]   A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens [J].
Sanchez, Larysa ;
Vesole, David H. ;
Richter, Joshua R. ;
Biran, Noa ;
Bilotti, Elizabeth ;
McBride, Laura ;
Anand, Palka ;
Ivanovski, Kristin ;
Siegel, David S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (03) :440-447
[40]   Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma [J].
Siegel, D. S. ;
Richardson, P. ;
Dimopoulos, M. ;
Moreau, P. ;
Mitsiades, C. ;
Weber, D. ;
Houp, J. ;
Gause, C. ;
Vuocolo, S. ;
Eid, J. ;
Graef, T. ;
Anderson, K. C. .
BLOOD CANCER JOURNAL, 2014, 4 :e182-e182
12345